Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is a frequently diagnosed cancer type, and many patients have already reached an advanced stage when diagnosed. Thus, it is crucial to develop a novel and efficient approach to diagnose and classify lung adenocarcinoma at an early stage. In our study, we combined in silico...
Main Authors: | Chang Li, Chen Tian, Yulan Zeng, Jinyan Liang, Qifan Yang, Feifei Gu, Yue Hu, Li Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.769711/full |
Similar Items
-
Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
by: Xiaoxuan Wu, et al.
Published: (2022-07-01) -
Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
by: Yuying Han, et al.
Published: (2020-11-01) -
Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
by: Sijin Sun, et al.
Published: (2021-10-01) -
The mitotic cell cycle‐associated nomogram predicts overall survival in lung adenocarcinoma
by: Xu He, et al.
Published: (2023-12-01) -
Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3–4 NSCLC patients
by: Chang Li, et al.
Published: (2022-02-01)